XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.21.1

Segment Information | 9 Months Ended
--- | ---
Mar. 31, 2021
Segment Information [Abstract] |
Segment Information | (2) Segment Information We have quantitatively and qualitatively determined that we operate in two operating segments, which are the Sleep and Respiratory Care segment and the SaaS segment. We evaluate the performance of our segments based on net revenues and income from operations. The accounting policies of the segments are the same as those described in note 2 of our consolidated financial statements included in our Form 10-K for the year ended June 30, 2020. Segment net revenues and segment income from operations do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed. Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, restructuring expenses, litigation settlement expenses, deferred revenue fair value adjustment, interest income, interest expense and other, net. We neither discretely allocate assets to our operating segments, nor does our Chief Operating Decision Maker evaluate the operating segments using discrete asset information. The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):
|  | Three Months Ended ‎March 31, |  | Nine Months Ended ‎March 31,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Net revenue by segment |  |  |  |  |  |  |  |  |  |  |  |
Total Sleep and Respiratory Care |  | $ | 674,931 |  | $ | 679,895 |  | $ | 2,042,909 |  | $ | 1,923,513
Software as a Service |  |  | 93,836 |  |  | 89,560 |  |  | 277,813 |  |  | 265,258
Deferred revenue fair value adjustment (1) |  |  | - |  |  | - |  |  | - |  |  | (2,102)
Total Software as a Service |  |  | 93,836 |  |  | 89,560 |  |  | 277,813 |  |  | 263,156
Total |  | $ | 768,767 |  | $ | 769,455 |  | $ | 2,320,722 |  | $ | 2,186,669
Depreciation and amortization by segment |  |  |  |  |  |  |  |  |  |  |  |
Sleep and Respiratory Care |  | $ | 13,589 |  | $ | 14,134 |  | $ | 39,979 |  | $ | 43,012
Software as a Service |  |  | 1,491 |  |  | 1,025 |  |  | 3,599 |  |  | 2,844
Amortization of acquired intangible assets and corporate assets |  |  | 24,908 |  |  | 24,105 |  |  | 76,456 |  |  | 70,485
Total |  | $ | 39,988 |  | $ | 39,264 |  | $ | 120,034 |  | $ | 116,341
Net operating profit by segment (2) |  |  |  |  |  |  |  |  |  |  |  |
Sleep and Respiratory Care (2) |  | $ | 253,693 |  | $ | 250,209 |  | $ | 763,534 |  | $ | 678,468
Software as a Service (2) |  |  | 23,052 |  |  | 18,738 |  |  | 70,929 |  |  | 63,874
Total |  | $ | 276,745 |  | $ | 268,947 |  | $ | 834,463 |  | $ | 742,342
Reconciling items |  |  |  |  |  |  |  |  |  |  |  |
Corporate costs |  | $ | 34,950 |  | $ | 31,039 |  | $ | 106,307 |  | $ | 94,933
Amortization of acquired intangible assets |  |  | 18,369 |  |  | 20,408 |  |  | 57,443 |  |  | 59,495
Restructuring expenses |  |  | - |  |  | - |  |  | 8,673 |  |  | -
Litigation settlement expenses |  |  | - |  |  | - |  |  | - |  |  | (600)
Deferred revenue fair value adjustment (1) |  |  | - |  |  | - |  |  | - |  |  | 2,102
Interest expense (income), net |  |  | 5,823 |  |  | 9,852 |  |  | 18,341 |  |  | 30,414
Loss attributable to equity method investments |  |  | 4,969 |  |  | 5,295 |  |  | 9,895 |  |  | 19,082
Other, net |  |  | (5,371) |  |  | 10,698 |  |  | (10,647) |  |  | 15,922
Income before income taxes |  | $ | 218,005 |  | $ | 191,655 |  | $ | 644,451 |  | $ | 520,994
(1) The deferred revenue fair value adjustment is a purchase price accounting adjustment related to MatrixCare which was acquired on November 13, 2018. (2)During the three and nine months ended March 31, 2021, we recorded $0.0 million and $2.8 million of impairment for our operating lease right-of-use asset, respectively. The impairment related to leases for office space and was recorded within net operating profit. The impairment for the nine months ended March 31, 2021 attributable to Sleep and Respiratory Care was $1.6 million and $1.2 million for SaaS.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration